More than 1,600 Americans have now been struck by a severe, sometimes fatal, lung illness tied to vaping.
Gefapixant has demonstrated efficacy in improving objective cough frequency and quality of life among individuals with chronic cough.
Nearly one-third of patients with cystic fibrosis-related hospitalizations have aspergillosis, which is associated with worse outcomes.
Patients with established chronic lung allograft dysfunction may have a higher risk for respiratory syncytial virus infections, but lung function decline does not appear to be significantly affected.
Lefamulin appears to be noninferior in safety and efficacy compared with moxifloxicin in the treatment of community-acquired bacterial pneumonia.
The American Thoracic Society has published a new clinical practice guideline detailing recommendations for various microbiologic laboratory testing approaches for diagnosing fungal infections in pulmonary and critical care, with a particular focus on immunocompromised patients.
Health authorities are looking at airborne droplets from water rides as a possible source of the outbreak.
The type of oral corticosteroid — prednisolone or dexamethasone — used to treat pediatric patients with croup appears to have no clinically significant effect on efficacy.